×
GETINGE EBIT 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
GETINGE ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
View More
GETINGE EBIT 2016-2024 | GNGBY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
GETINGE ebit from 2016 to 2024. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$148.1B
Elevance Health (ELV)
$90.8B
CVS Health (CVS)
$83.7B
Cencora (COR)
$47.6B
DiDi Global (DIDIY)
$23.1B
Natera (NTRA)
$22.8B
ICON (ICLR)
$15.8B
Doximity (DOCS)
$14.3B
BioMerieux (BMXMF)
$14.1B
Revvity (RVTY)
$14B
Viatris (VTRS)
$13B
Solventum (SOLV)
$12.8B
Avantor (AVTR)
$12B
CochLear (CHEOY)
$11.5B
Medpace Holdings (MEDP)
$10.5B
HealthEquity (HQY)
$9.9B
EUROFINS SCIENT (ERFSF)
$9.5B
Sonic Healthcare (SKHHY)
$8.8B
Charles River Laboratories (CRL)
$8.4B
Amplifon S.p.A (AMFPF)
$6.2B
Bausch + Lomb (BLCO)
$5.7B
Organon (OGN)
$3.9B
Sotera Health (SHC)
$3.9B
BrightSpring Health Services (BTSG)
$3.6B
Surgery Partners (SGRY)
$3.3B
GeneDx Holdings (WGS)
$3.1B
Concentras Parent (CON)
$3B
Alignment Healthcare (ALHC)
$2.7B
Teladoc Health (TDOC)
$2.4B
Ardent Health Partners (ARDT)
$2.1B